Webinar on Drafting a Software VandV Documentation Package and Protocol
The verification and validation of medical software is coming under increased scrutiny by the U.S. FDA.
This webinar will address the use of the FDA, DAMP, and other applicable industry software validation models, coupled with the ISO 14971 / ICH Q9 Risk Management models, to structure, run, and document acceptable software validations. The FDA and other regulatory agencies have stated that software validation can only be accomplished effectively if "risk-based". How can this be realistly accomplished.
This webinar will address software that is:
In Production and Test Equipment; and
The Quality System.
A manufacturer is responsible to identify these requirements and implement them into an effective software V&V process.
Areas Covered in the Session:
Verification or Validation
Current Regulatory Expectations and “Hot Buttons”
The Project Validation Plan
Product and Process / Equipment Software V&V
When and How to Use DQ, IQ, OQ, PQ
The FDA's 11 Key Elements
"White Box" and "Black Box" Validations
Who Will Benefit:
Senior management, Project Leaders, Internal / External consultants
Mid-level Management and Supervisory Personnel
Quality Systems Personnel / QAE
R&D and Engineering Staff
New Product Development Personnel
Medical Device, Equipment / Process SW Programmers
John E. Lincoln is a medical device and regulatory affairs consultant. He has helped companies to implement or modify their GMP systems and procedures, product risk management, U.S. FDA responses. In addition, he has successfully designed, written and run all types of process, equipment and software qualifications/validations, which have passed FDA audit or submission scrutiny, and described in peer-reviewed technical articles, and workshops, world wide.
161 Mission Falls Lane,
Suite 216, Fremont, CA 94539, USA
Event Link - http://bit.ly/MQdBrI